Sep 1, 2019 • 44M

Brotherly Love: Harvard Business School Grad Rich Horgan's Mission to Fight Duchenne muscular dystrophy (DMD) and other Rare Diseases

 
0:00
-43:32
Open in playerListen on);

Appears in this episode

Network Capital
Network Capital’s (NC) mission is to democratize inspiration and make personalized mentoring and career guidance accessible to every person on the planet. We are a global community of more than 200,000 peer mentors from 104 countries who learn with and from each other. We are a subscription based career content and mentoring community 1. Serve as your personalized career coach in the form of global tribe of mentors. No matter what you are looking for, someone on Network Capital has done it. 2. Offer carefully curated jobs and internships 3. Access to Network Capital TV and all subgroups
Episode details
Comments

Rich Horgan is the Founder and President of Cure Rare Disease. Rich is also a Blavatnik Fellow at Harvard Business School with a deep passion for Duchenne muscular dystrophy (DMD) and other rare diseases. With a younger brother impacted by the disease, Rich has a strong interest in accelerating promising treatments for the disease. He formed a collaboration with world-class researchers and clinicians to pioneer the development of customized therapies for Duchenne and other rare diseases. He also launched a company, Myofinity Biosciences, to focus on the commercialization of effective therapies for DMD and is working in collaboration with leading scientists in the field. Prior to making his foray into biotech, Rich had extensive experience working in new business development at Corning Incorporated where he led the successful launch of a new Willow® Glass product. He also launched a successful car washing business in upstate New York. He holds a BS from Cornell University where he graduated as summa cum laude and an MBA from Harvard Business School.

We encourage you to donate using this link: https://cureraredisease.org/support-us/one-time-donation/